Tag: autologous stem cell transplant (ASCT)

lymphoma
January 27, 2023/Cancer/Research

Pembrolizumab Following Autologous Stem Cell Transplantation Shows Promise in T-Cell Non-Hodgkin’s Lymphoma

62% of patients were progression-free at 18 months post-transplantation

BMT Tandem 2015
February 11, 2015/Cancer/Blood Cancers

Bortezomib-based Induction Therapy Before Transplant Benefits Amyloidosis Patients

Cleveland Clinic study finds regimen helps improve outcomes

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad